drug
abatacept
Marketedupdated 3mo agoby Bristol-Myers Squibb Co
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4indications
investigational
Rheumatoid Arthritis
all catalysts(1)
Trials studying abatacept
- phase1Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects
- phase2Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- phase1Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
- phase2A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- phase2Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- phase2Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- phase2Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
- phase3Abatacept in Immune Checkpoint Inhibitor Myocarditis
News(3)
- An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.In fact, the former lost tens of billions of dollars in market value following reports of a potential tie-up between the pharmaceutical giants.biopharma_dive · 8d ago
- BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delaysStrong quarterly results are prompting Bristol Myers Squibb to lift its 2026 outlook, though the company is facing another delay for key Cobenfy Alzheimer’s data and a pushed-back readout for milve…biospace · 12d ago
- Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlookInvestors are still waiting to see whether Bristol Myers and Regeneron’s pipelines will deliver, while Biogen was lifted by better-than-expected results for newer drugs like Leqembi and Skyclarys.biopharma_dive · 3mo ago
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that